Science Feb 12, 2026 Mechanisms linking cytoplasmic decay of translation-defective mRNA to transcriptional adaptation | Science
FierceBiotech Feb 12, 2026 UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing
Endpoints News Feb 11, 2026 Prasad overruled vaccine review team, office director on Moderna flu shot
FierceBiotech Feb 11, 2026 Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale
Endpoints News Feb 10, 2026 Moderna accuses FDA of shifting standard as agency refuses flu shot review
FierceBiotech Jan 30, 2026 Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
FierceBiotech Jan 23, 2026 Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials
Moderna Jan 23, 2026 Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials - Fierce Biotech